SCHEMBL6089483

SCHEMBL6089483

CC(C)Oc1ccc(-c2ccc3c(NC(=O)c4ccc(Cl)cc4)c(C(=O)O)n(Cc4cccc(Cl)c4)c3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
PTGES O14684 1/20 0.43
ABCB1 P08183 1/20 0.43
MDM2 Q00987 3/20 0.42
MCL1 Q07820 2/20 0.42
PPARG P37231 8/20 0.42
PPARA Q07869 5/20 0.42
CYP2C9 P11712 1/20 0.42
EGFR P00533 1/20 0.42
CHRM4 P08173 1/20 0.42
ADRB1 P08588 1/20 0.42
ADRA2A P08913 1/20 0.42
ALOX5 P09917 1/20 0.42
ADRB3 P13945 1/20 0.42
DRD2 P14416 1/20 0.42
ADRA2B P18089 1/20 0.42
CHRM3 P20309 1/20 0.42
TACR2 P21452 1/20 0.42
DRD1 P21728 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6091379 0.95 YWHAH (0.45) TP53POLBPTGESABCB1MDM2
SCHEMBL6091176 0.92 PTGES (0.43) TP53POLBPTGESMDM2MCL1
SCHEMBL6090079 0.92 TP53 (0.42) TP53POLBPTGESMDM2MCL1
SCHEMBL6091437 0.92 PTGES (0.42) TP53POLBPTGESMDM2MCL1
SCHEMBL6091449 0.92 PTGES (0.42) TP53POLBPTGESMDM2MCL1
SCHEMBL5749488 0.89 PTGER4 (0.46) PTGESABCB1PPARGPTGER4PTGDR
SCHEMBL6092421 0.87 PTGES (0.57) PTGESABCB1PPARGPPARACYP2C9
SCHEMBL6092460 0.87 RXFP1 (0.44) TP53POLBABCB1PPARGCYP2C9
SCHEMBL6093040 0.87 SERPINE1 (0.45) PTGESABCB1PPARGSLC2A1
SCHEMBL6090090 0.87 PPARG (0.41) TP53ABCB1PPARGPTGER4SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 TP53 2032/4885POLB 3825/4885PTGES 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.